If CHA2DS2 VASc 2 w contraindications to oral anticoagulation or high risk of major bleeding percutaneous LAAO is reasonable option

By rray, 26 January, 2024
Exclude Patient Type Detail Header
No
Detail Type
Text
Patient Type Detail Header (Long)
If <a href=https://online.epocrates.com/contextuallink/medCalc/AtrialFibCHADSVASc.htm?activeMedCalcName=CHADS-VASc+Score+for+Stroke+Risk+in+Arial+Fibrillation+%28CHA%5B2%5DS%5B2%5D-VASc%29><u>CHA<sub>2</sub>DS<sub>2</sub>-VASc</u></a> ≥2 w/ contraindications to oral anticoagulation or high risk of major bleeding, percutaneous LAAO is reasonable option.